Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy

被引:18
作者
Doran, ST
Falk, GL
Somorjai, RL
Lean, CL
Himmelreich, U
Philips, J
Russell, P
Dolenko, B
Nikulin, AE
Mountford, CE
机构
[1] Univ Sydney, Inst Magnet Resonance Res, St Leonards, NSW 1590, Australia
[2] Univ Sydney, Dept Magnet Resonance Med, St Leonards, NSW 1590, Australia
[3] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia
[4] Strathfield Private Hosp, Strathfield, NSW 2135, Australia
[5] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada
关键词
Barrett's epithelium; esophagus; pathology; magnetic resonance spectroscopy; adenocarcinoma; mathematical statistical analysis;
D O I
10.1016/S0002-9610(02)01374-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Barrett's esophagus is thought to be a precursor of adenocarcinoma. The incidence of adenocarcinoma of the lower esophagus in the Western world is rising and accounts for more than 40% of esophageal carcinomas in males. It is not possible to identify which Barrett's patients are at high risk of developing malignancy. Here we applied a statistical classification strategy to the analysis of magnetic resonance spectroscopy and histopathological data from esophageal biopsies to ascertain whether this risk could be identified in Barrett's patients. Methods: Tissue specimens from 72 patients (29 noncancer-bearing and 43 cancer-bearing) were analyzed by one-dimensional proton magnetic resonance spectroscopy at 8.5 Tesla. Diagnostic correlation was performed between the magnetic resonance spectra and histopathology. The magnetic resonance magnitude spectra were preprocessed, followed by identification of optimal spectral regions, and were then classified by cross-validated linear discriminant analysis of rank orders of the first derivative of magnetic resonance spectra. Results: Magnetic resonance spectroscopy combined with a statistical classification strategy analysis distinguished normal esophagus from adenocarcinoma and Barrett's epithelium with an accuracy of 100%. Barrett's epithelium and adenocarcinoma were distinguished with an accuracy of 98.6% but only when 4 of the Barrett's specimens and 7 of the carcinoma specimens, determined to be "fuzzy" (ie, unable to be accurately assigned to either class) were withdrawn. The 7 cancer and 4 Barrett's specimens, determined to be "fuzzy" using the Barrett's versus cancer (B versus Q classifier, were submitted to the other two classifiers (Barrett's versus normal [B versus N] and normal versus cancer [N versus C], respectively). The 4 Barrett's specimens were assigned to Barrett's by the N versus B classifier and to normal (n 2) or cancer (n = 2) classes by the N versus C classifer. The 7 cancer specimens were crisply assigned to the cancer class (N versus Q, or for the B versus N classifier, to the Barrett's class (ie, more similar to Barrett's than to normal tissue). Visual inspection of the spectra from histologically identified Barrett's epithelium showed a gradation from normal to carcinoma. Conclusions: Proton magnetic resonance spectroscopy of esophageal biopsies combined with a statistical classification strategy data analysis provides a robust diagnosis with a high degree of accuracy for discriminating normal epithelium from esophageal adenocarcinoma and Barrett's esophagus. Different spectral. categories of Barrett's epithelium were identified both by visual inspection and by statistical classification strategy, possibly reflecting the risk of future malignant transformation. (C) 2003 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 31 条
[1]  
BARRY P, 1998, OESOPHAGOGASTRIC JUN, P1122
[2]   RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
BLOT, WJ ;
DEVESA, SS ;
KNELLER, RW ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10) :1287-1289
[3]   CLONAL ORDERING OF 17P AND 5Q ALLELIC LOSSES IN BARRETT DYSPLASIA AND ADENOCARCINOMA [J].
BLOUNT, PL ;
MELTZER, SJ ;
YIN, J ;
HUANG, Y ;
KRASNA, MJ ;
REID, BJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3221-3225
[4]  
CLARK GWB, 1994, ARCH SURG-CHICAGO, V129, P609
[5]   PROTON MR AND HUMAN CERVICAL NEOPLASIA - EX-VIVO SPECTROSCOPY ALLOWS DISTINCTION OF INVASIVE-CARCINOMA OF THE CERVIX FROM CARCINOMA IN-SITU AND OTHER PREINVASIVE LESIONS [J].
DELIKATNY, EJ ;
RUSSELL, P ;
HUNTER, JC ;
HANCOCK, R ;
ATKINSON, KH ;
VANHAAFTENDAY, C ;
MOUNTFORD, CE .
RADIOLOGY, 1993, 188 (03) :791-796
[6]  
Efron B., 1993, MONOGR STAT APPL PRO, V57
[7]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[8]  
Hahn P, 1997, CANCER RES, V57, P3398
[9]   Barrett's esophagus - The significance of p53 in clinical practice [J].
Ireland, AP ;
Clark, GWB ;
DeMeester, TR .
ANNALS OF SURGERY, 1997, 225 (01) :17-30
[10]   DIAGNOSIS OF FOLLICULAR THYROID LESIONS BY PROTON MAGNETIC-RESONANCE ON FINE-NEEDLE BIOPSY [J].
LEAN, CL ;
DELBRIDGE, L ;
RUSSELL, P ;
MAY, GL ;
MACKINNON, WB ;
ROMAN, S ;
FAHEY, TJ ;
DOWD, S ;
MOUNTFORD, CE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1306-1311